Name: UMIN ID:
Unique ID issued by UMIN | UMIN000024165 |
---|---|
Receipt number | R000027823 |
Scientific Title | Efficacy and safety of new drugs for induction, autologous stem cell transplantation, consolidation and maintenance therapy in patients with newly diagnosed symptomatic multiple myeloma: a phase 2 study |
Date of disclosure of the study information | 2017/02/01 |
Last modified on | 2017/10/05 09:51:26 |
No. | Disposal | Last modified on | Item of update | |
---|---|---|---|---|
1 | Insert | 2016/09/26 13:14:38 | ||
2 | Update | 2016/11/30 13:24:11 | Key inclusion criteria |
|
3 | Update | 2016/11/30 13:28:22 | Organization Organization |
|
4 | Update | 2016/11/30 13:29:04 | Date of protocol fixation |
|
5 | Update | 2017/02/01 09:55:51 | Interventions/Control_1 |
|
6 | Update | 2017/10/05 09:51:26 | Recruitment status |